VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW
FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.
FlandersBio beschikt over een geüpdate databank met een overzicht van de Vlaamse bedrijven met biotechactiviteit en alle FlandersBio-leden. De databank verleent een makkelijke en vlugge toegang tot de lokale biowetenschappen-gemeenschap.
Flen Pharma develops innovative topical products for improving the quality of life of patients that suffer from infections or inflammations. Flen Pharma started its activities in wound care - including burns, venous and diabetic ulcers, bedsores, grazes and post-operative wounds - and wound-bed preparation.
Flen Pharma was established as a result of research performed by its CEO Philippe Sollie, a pharmacist, during the 1990s. Activities focus on the discovery and development of novel wound treatments that significantly enhance the healing process, provide improved patient comfort and offer advanced methods in the clinical setting.
Products currently on the market include Flamigel(R), Flamispray (R), Flaminal(R) Forte and Flaminal(R) Hydro, which are based on the moist wound healing principle and originate from patented biological antimicrobial and antiinflammatory applications. Flamirins (R), Flamiclens (R) are both isotonic, slightly acidic wound rinse solutions used in hospital and home care settings. Ongoing research at the company’s laboratories a is focused on the continuing development of products for the topical treatment of inflammation and infection.
The company's expertise is situated in following domains:
Flaminal® Forte, Flaminal® Hydro, Flamirins®
Department of Pharmaceutical Sciences and Biopharmacy, University of Antwerp, Belgium.
Phone: +32 3 825 70 63
Fax: +32 3 226 46 58
Foundation date: 2000